|
[1]
|
Formulation and Evaluation of Teneligliptin Nanosuspension
Research Journal of Pharmacy and Technology,
2024
DOI:10.52711/0974-360X.2024.00015
|
|
|
|
|
[2]
|
Expert Consensus on Dipeptidyl Peptidase-4 Inhibitor-Based Therapies in the Modern Era of Type 2 Diabetes Mellitus Management in India
Cureus,
2024
DOI:10.7759/cureus.61766
|
|
|
|
|
[3]
|
Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use
Pharmacy & Pharmacology,
2023
DOI:10.19163/2307-9266-2023-11-1-19-47
|
|
|
|
|
[4]
|
Insight into Structure Activity Relationship of DPP-4 Inhibitors for Development of Antidiabetic Agents
Molecules,
2023
DOI:10.3390/molecules28155860
|
|
|
|
|
[5]
|
Formulation and Characterization of Gastroretentive Drug Delivery System of Teneligliptin
Research Journal of Pharmacy and Technology,
2023
DOI:10.52711/0974-360X.2023.00814
|
|
|
|
|
[6]
|
Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: 52-Week Results from a Prospective Observational Study
Diabetes Therapy,
2021
DOI:10.1007/s13300-021-01148-1
|
|
|
|
|
[7]
|
COMPARISON OF EFFICACY AND SAFETY OF TENELIGLIPTIN VERSUS SITAGLIPTIN AS ADD ON TO METFORMIN IN TYPE 2 DIABETES MELLITUS AT JLNMC, BHAGALPUR, BIHAR
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH,
2020
DOI:10.36106/ijsr/7825840
|
|
|
|
|
[8]
|
Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2)
Diabetes Therapy,
2020
DOI:10.1007/s13300-020-00880-4
|
|
|
|
|
[9]
|
Effect of glimepiride on the pharmacokinetics of teneligliptin in healthy Korean subjects
Journal of Clinical Pharmacy and Therapeutics,
2019
DOI:10.1111/jcpt.12848
|
|
|
|
|
[10]
|
Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: A 12-Week Interim Report
Diabetes Therapy,
2019
DOI:10.1007/s13300-019-0628-0
|
|
|
|
|
[11]
|
Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: A 12-Week Interim Report
Diabetes Therapy,
2019
DOI:10.1007/s13300-019-0628-0
|
|
|
|
|
[12]
|
Determination of Dipeptidyl Peptidase-4 Inhibitors by Spectrophotometric and Chromatographic Methods
Journal of Analytical Chemistry,
2018
DOI:10.1134/S1061934818040032
|
|
|
|
|
[13]
|
Diffuse erythematous rash after teneligliptin therapy: A case report
Journal of Family Medicine and Primary Care,
2018
DOI:10.4103/jfmpc.jfmpc_283_18
|
|
|
|